Chao Yu
-
- COVID-19 Clinical Research Studies 5
- SARS-CoV-2 and COVID-19 Research 4
-
- Liver Disease Diagnosis and Treatment 6
-
- Allergic Rhinitis and Sensitization 4
-
- IL-33, ST2, and ILC Pathways 4
-
- Diet, Metabolism, and Disease 4
-
- Alcohol Consumption and Health Effects 4
-
- Asthma and respiratory diseases 4
- Partner nations
- ChinaHong KongUnited States
In The Last Decade
Chao Yu
49 papers receiving 862 citations
Hit Papers
Peers
Comparison fields: 5 of 106
- Biological Psychiatry 29
- Cancer Research 146
- Complementary and alternative medicine 77
- Infectious Diseases 95
- Molecular Biology 334
Countries citing papers authored by Chao Yu
This map shows the geographic impact of Chao Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chao Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chao Yu more than expected).
Fields of papers citing papers by Chao Yu
This network shows the impact of papers produced by Chao Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chao Yu. The network helps show where Chao Yu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Chao Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 2 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 2 | |
| 7 | 2024 | 0 | |
| 8 | 2023 | 7 | |
| 9 | 2023 | 1 | |
| 10 | 2023 | 10 | |
| 11 | Gut Microbially Produced Indole-3-Propionic Acid Inhibits Atherosclerosis by Promoting Reverse Cholesterol Transport and Its Deficiency Is Causally Related to Atherosclerotic Cardiovascular Diseasebreakdown → | 2022 | 150 |
| 12 | 2021 | 15 | |
| 13 | 2021 | 8 | |
| 14 | 2020 | 32 | |
| 15 | 2020 | 2 | |
| 16 | 2017 | 27 | |
| 17 | 2017 | 4 | |
| 18 | 2013 | 22 | |
| 19 | 2011 | 34 | |
| 20 | 2011 | 22 |
About Chao Yu
Chao Yu is a scholar working on Immunology and Allergy, Complementary and alternative medicine and Developmental Neuroscience, having authored 52 papers that have together received 873 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (6 papers), COVID-19 Clinical Research Studies (5 papers), SARS-CoV-2 and COVID-19 Research (4 papers), Allergic Rhinitis and Sensitization (4 papers), IL-33, ST2, and ILC Pathways (4 papers), Diet, Metabolism, and Disease (4 papers), Alcohol Consumption and Health Effects (4 papers) and Asthma and respiratory diseases (4 papers). The work is most often cited by research in Biological Psychiatry (29 citations), Cancer Research (146 citations) and Complementary and alternative medicine (77 citations). Chao Yu has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Wenhua Ling, Jieshou Li, Hongliang Xue, Weiming Zhu, Yi Li, Yuqing Deng, Yuan Zhang, Xu Chen, Chen Shen and Yan Yang.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.